Preclinical Characterization of Signal Transducer and Activator of Transcription 3 Small Molecule Inhibitors for Primary and Metastatic Brain Cancer Therapy
Hikmat Assi(Eastern Michigan University), María G. Castro(Cedars-Sinai Medical Center)
Cited by 34
Related Papers
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
|PLoS Medicine|2009|366
Combined Immunostimulation and Conditional Cytotoxic Gene Therapy Provide Long-term Survival in a Large Glioma Model
|Cancer Research|2005|127
Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
|Neoplasia|2012|62